Proteinase-activated receptor 2 is an anti-inflammatory signal for colonic lamina propria lymphocytes in a mouse model of colitis
- Stefano Fiorucci*,†,
- Andrea Mencarelli*,
- Barbara Palazzetti*,
- Eleonora Distrutti*,
- Nathalie Vergnolle‡,
- Morley D. Hollenberg‡,
- John L. Wallace‡,
- Antonio Morelli*, and
- Giuseppe Cirino§
- *Clinica di Gastroenterologia ed Endoscopia Digestiva, Dipartimento di Medicina Clinica, Patologia Univesita di Perugia, Perugia 06122, Italy; ‡Gastrointestinal and Endocrine Research Groups, Departments of Pharmacology and Therapeutics, University of Calgary, Calgary, AL, Canada T2M 4M1; and §Dipartimento di Farmacologia Sperimentale, Universitá di Napoli, Naples 80131, Italy
-
Edited by Louis J. Ignarro, University of California School of Medicine, Los Angeles, CA, and approved September 24, 2001 (received for review July 20, 2001)
Abstract
The proteinase-activated receptor 2 (PAR-2) is a member of a family of G protein-coupled receptors for proteases. Proteases cleave PARs within the extracellular N-terminal domains to expose tethered ligands that bind to and activate the cleaved receptors. PAR-2 is highly expressed in colon in epithelial and neuronal elements. In this study we show that PAR-2 activation prevents the development and induces healing of T helper cell type 1-mediated experimental colitis induced by intrarectal administration of 2,4,6-trinitrobenzene sulfonic acid (TNBS) in mice. A role for PAR-2 in the protection against colon inflammation was explored by the use of SLIGRL-NH2, a synthetic peptide that corresponds to the mouse tethered ligand exposed after PAR-2 cleavage. TNBS-induced colitis was dose-dependently reduced by the administration of SLIGRL-NH2, whereas the scramble control peptide, LSIGRL-NH2, was uneffective. This beneficial effect was reflected by increased survival rates, improvement of macroscopic and histologic scores, decrease in mucosal content of T helper cell type 1 cytokines, protein, and mRNA, and a diminished myeloperoxidase activity. SLIGRL-NH2, but not the scramble peptide, directly inhibited IFN-γ secretion and CD44 expression on lamina propria T lymphocytes. Protection exerted by PAR-2 in TNBS-treated mice was reverted by injecting mice with a truncated form of calcitonin gene-related peptide and by sensory neurons ablation with the neurotoxin capsaicin. Collectively, these studies show that PAR-2 is an anti-inflammatory receptor in the colon and suggest that PAR-2 ligands might be effective in the treatment of inflammatory bowel diseases.
Footnotes
-
↵ † To whom reprint requests should be addressed. E-mail: fiorucci{at}unipg.it.
-
This paper was submitted directly (Track II) to the PNAS office.
- Abbreviations:
- CGRP,
- calcitonin gene-related peptide;
- IBD,
- inflammatory bowel disease;
- iNOS,
- inducible NO synthase;
- LP,
- lamina propria;
- LPT,
- LP T cells;
- PAR,
- proteinase-activated receptor;
- PAR AP,
- PAR agonistic peptide;
- Th-1,
- T helper cell type 1;
- TNBS,
- 2,4,6-trinitrobenzene sulfonic acid;
- TNF-α,
- tumor necrosis factor α
- Copyright © 2001, The National Academy of Sciences





